
Zvoľte si etiketu
zobrazené priamo na liekovkeACE-031
Muscle Building
- Odosielame z Nemecka
Objednávka
- DHL so sledovaním zásielky
- Diskrétne balenie
V skratke
ACE-031 v číslach
Kľúčové údaje z nášho lexikónu.
Celé heslo v lexikóne- Class
- ActRIIB-Fcmyostatin/activin trap
- Half-life
- longfusion protein
- Use
- Subcutaneousno established protocol
- Sizes
- 1 mg1 size in the shop
What studies show
All 2 sources in the lexicon- Attie et al., Muscle & Nerve, 2013
ACE-031 in boys with Duchenne muscular dystrophy (study stopped early) (opens in a new tab)
Campbell et al., Muscle & Nerve, 2017
Hodnotenia
Čo hovoria zákazníci
Len skutočné objednávky, ktoré obsahovali ACE-031.
Všetky hodnoteniaPre ACE-031 zatiaľ neexistuje laboratórna analýza. Hlasujte za toDajte si to otestovať sami, polovicu zaplatímeVšetky laboratórne analýzy
Znalosti
Všetko o ACE-031
Podrobné informácie pripravujeme.
Hodí sa priobjednať
Čo k tomu potrebujete
Bakteriostatická voda sa do košíka pridá automaticky. Striekačky a tampóny jedným kliknutím.
Inzulínové striekačky
10 ks · 5.50 €
Alkoholové tampóny
50 ks · 10 €
Koľko vody?
Jednotky na striekačke pre vašu veľkosť liekovky.
Otvoriť kalkulačku →What is ACE-031?
A large fusion protein: the outer part of the activin receptor IIB, linked to a piece of an antibody (IgG1 Fc). It binds myostatin and related messengers in the blood before they reach the receptor on muscle. The compound name is ramatercept.
What did the first human study show?
48 healthy postmenopausal women received a single dose at ascending levels or placebo. In the group with the highest study dose lean mass rose by 3.3 percent and thigh muscle volume by 5.1 percent after 29 days. The half-life was 10 to 15 days.
Why was development stopped?
In the trial in boys with Duchenne muscular dystrophy nosebleeds and telangiectasias occurred, meaning widened small blood vessels. The trial was stopped after the second dosing regimen because of potential safety concerns. The activin receptor IIB acts not only on muscle but also on vessels.
Was there a benefit in Duchenne?
Only trends. The 6-minute walk distance tended to be maintained in the ACE-031 groups while it declined on placebo. There were also trends towards more lean mass and bone density and less fat mass. None of this was statistically significant.
Is ACE-031 approved?
No. ChEMBL lists ramatercept with phase 2 as the highest phase. ClinicalTrials.gov lists four trials from 2008 to 2011, both phase 2 trials were terminated early (as of 26 October 2026).
What do animal studies show?
In marmosets lean mass increased over 14 weeks on ACE-031, muscle fibres became thicker and muscle force rose. This did not happen in the control group. The authors see this as a pointer for muscle diseases in humans.
Súvisiace
Súvisiace produkty
IGF-1 LR3
Peptidy · Rast a svaly Rast a svaly
2 veľkosti
= od 11.6 €/liekovka
MGF
Peptidy · Rast a svaly Rast a svaly
1 veľkosť
= 13.2 €/liekovka
PEG-MGF
Peptidy · Rast a svaly Rast a svaly
1 veľkosť
= 22 €/liekovka
FST-344 (Follistatin)
Peptidy · Rast a svaly Rast a svaly
1 veľkosť
= 53.2 €/liekovka
ACE-031